Infection with feline herpesvirus-1 (FHV-1) is a major cause of upper respiratory and ocular diseases in Felidae. We report the first complete genomic sequence of FHV-1, as well as the construction and characterization of a bacterial artificial chromosome (BAC) clone of FHV-1, which contains the entire FHV-1 genome and has the BAC vector inserted at the left end of U L . Complete genomic sequences were derived from both the FHV-1 BAC clone and purified virion DNA. The FHV-1 genome is 135,797 bp in size with an overall G + C content of 45%. A total of 78 open reading frames were predicted, encoding 74 distinct proteins. The gene arrangement is collinear with that of most sequenced varicelloviruses. The virus regenerated from the BAC was very similar to the parental C-27 strain in vitro in terms of plaque morphology and growth characteristics and highly virulent in cats in a preliminary in vivo study.
Introduction
Feline herpesvirus-1 (FHV-1) is a significant viral pathogen of Felidae, first isolated in 1957 by Crandell and Maurer (1958) . FHV-1 accounts for approximately 50% of all diagnosed viral upper respiratory infections in cats and is also a significant cause of ocular lesions (Nasisse, 1990) . The pathobiology of FHV-1 has been reviewed (Gaskell et al., 2007; Maggs, 2005; Stiles, 2003) . Briefly, following entry via the oronasal route, FHV-1 replicates extensively in the mucosae of the upper respiratory tract resulting in high fever, depression, anorexia, sneezing, conjunctivitis, keratitis, and ocular and nasal discharge. The acute phase of the disease is followed by lifelong latency, a hallmark of herpesvirus infections. During the latent stage, viral DNA appears to persist mainly in sensory ganglia. Different biological stresses, or administration of corticosteroids, can induce the necessary biochemical stimuli in latently infected cells that lead to renewed production of infectious virus, which can travel to the periphery and is a potential source of viral transmission. In addition to the primary disease, FHV-1 is also a contributor to feline chronic rhinosinusitis (Johnson and Maggs, 2005) . Despite its high morbidity and worldwide distribution, currently available vaccines cannot totally protect cats from field virus infection and, as a consequence, from field virus latency (Gaskell and Povey, 1979; Tham and Studdert, 1987) . In addition, some commercial vaccines are avirulent when administered subcutaneously, but virulent when administered oronasally (Kruger et al., 1996; Povey, 1979) . Since reactivation of latent FHV-1 is common, vaccinated cats may act as asymptomatic carriers and contribute to the spread of virulent virus (Gaskell and Povey, 1982) .
Our knowledge of FHV-1 at the molecular level is still limited. FHV-1 is a member of Herpesviridae family, Alphaherpesvirinae subfamily, genus Varicellovirus (Davison et al., 2009 ). All FHV-1 isolates appear to be relatively similar, and belong to one serotype. The FHV-1 genome, mapped by restriction endonuclease digestion techniques, is approximately 134 kb, and has a typical type D structure similar to other varicelloviruses (Fig. 1A) . The double-stranded DNA genome consists of two segments of unique sequences, known as unique long (U L ) and unique short (U S ). The U S region is flanked by a pair of identical but inverted repeat sequences, known as terminal repeat short (TR S ) and inverted repeat short (IR S ) (Grail et al., 1991; Rota et al., 1986) . Alphaherpesviruses usually encode 65-80 open reading frames (ORFs) (Alba et al., 2001) . FHV-1 has been shown to contain 23 virionassociated proteins (Fargeaud et al., 1984) . Eight glycoproteins have previously been identified and designated as gB, gC, gD, gE, gG, gH, gI, Virology 401 (2010) [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] and gL. Knowledge about the functions of these glycoproteins has been reviewed by Maeda et al. (1998) , although it is clear that much more work is needed to define their actual functions and roles in viral pathogenesis and immunity. In recent years, many herpesvirus genomes of human and veterinary medical importance have been completely sequenced and annotated, among them herpes simplex virus types 1 (HSV-1) (McGeoch et al., 1988) and 2 (HSV-2) (Dolan et al., 1998) , varicella-zoster virus (VZV) (Davison and Scott, 1986) , bovine herpesvirus types 1 (BHV-1) (Schwyzer and Ackermann, 1996) and 5 (BHV-5) (Delhon et al., 2003) , equine herpesvirus types 1 (EHV-1) (Telford et al., 1992) and 4 (EHV-4) (Telford et al., 1998 ), Marek's disease virus (MDV) (Lee et al., 2000; Tulman et al., 2000) , and pseudorabies virus (PRV) (Klupp et al., 2004) . Before this report, only portions of the FHV-1 genomic sequence were available.
Bacterial artificial chromosomes (BACs) are single copy F-factorbased plasmid vectors that can stably hold 300 kb or more of foreign DNA (Shizuya et al., 1992) . BACs have advantages over other vectors including higher cloning capacity, greater stability in Escherichia coli, and the efficiency of manipulation. Because of these advantages, BACs have been widely used for cloning of entire herpesvirus genomes, and the resulting clones have been shown to be infectious. Herpesviruses that have been cloned as BACs include HSV-1 (Saeki et al., 1998; Stavropoulos and Strathdee, 1998) , Epstein-Barr virus (Delecluse et al., 1998) , human cytomegalovirus (Borst et al., 1999; Marchini et al., 2001; Yu et al., 2002) , PRV (Smith and Enquist, 1999) , EHV-1 (Hansen et al., 2006; Rudolph et al., 2002) , MDV (Schumacher et al., 2000; Niikura et al., 2006) , canine herpesvirus (Arii et al., 2006; Strive et al., 2006) , and FHV-1 (Costes et al., 2006) .
In this report, we present the first complete and annotated genomic sequence of FHV-1, as well as a BAC clone that contains the entire FHV-1 genome and is infectious both in vitro and in vivo.
Results

Cloning of the FHV-1 genome as a BAC
The C-27 strain FHV-1 genome was cloned as a BAC. US4, which encodes gG, was selected as the target site for the BAC cassette insertion because it has been shown to be nonessential for virus growth in several alphaherpesviruses (Balan et al., 1994; Baranowski et al., 1996) including FHV-1 (Costes et al., 2006) . Analyses later revealed that the BAC vector was in fact inserted near the genomic terminus at the U L end, 124 bp upstream from the start codon of UL56 (Fig. 1) . In addition, an unknown sequence of 2570 bp in size was present immediately upstream of the BAC vector.
Restriction pattern analysis was used to examine the overall integrity of the FHV-1 genome in the BAC clone. The SalI digestion pattern of the BAC clone was very similar to that of the parent strain (Fig. 2) . G and M fragments that contained genomic termini would have become one fragment when the genome circularized but were instead resolved as three fragments because of the introduction of additional SalI sites by the BAC insertion. The first two of these fragments, 9445 and 9171 bp in size, form a triple band with the H fragment. The other fragment was 6384 bp in size. The K fragment has different sizes among bacterial clones. A clone that had a SalI pattern representative of most bacterial clones and most similar to that of the C-27 strain was used for all subsequent studies.
In addition to the restriction pattern analysis, PCR assays were used to examine the insertion of the BAC vector. Using primers targeting different BAC vector components (Table 1) , including the enhanced green fluorescence protein (EGFP) gene (RM0901 and RM0944, or RM0945 and RM0911), the chloramphenicol resistance gene (RM0955 and RM0956), and the bacterial origin of replication (RM0957 and RM0958), PCR assays confirmed that the BAC vector was inserted into the FHV-1 genome (data not shown). However, PCR primers targeted to the expected junction between the BAC vector and the viral sequence (RM0910 and RM0959) failed, and primers RM0988 and RM0989 amplified the full length of an intact US4. These results suggested that the BAC was inserted into the FHV-1 genome but not into US4 as intended.
Sequencing of the FHV-1 genome
Using "454" next generation sequencing technology, complete genome sequences were generated de novo for both the viral genomic DNA and BAC clone, and then compared to one another. The sequence assembly of the BAC clone represented 97.62% of the entire FHV-1 genome with an average read depth of 33×. The assembly of the viral DNA represented 97.52% of the entire genome with an average read depth of 25×.
To complete the sequences, gaps were filled by primer walking, using both pure viral DNA and BAC DNA as template. Three major gaps were present in both assemblies. Gap no. 1 represents the junction of U L and IR S , gap no. 2 was located inside both IR S and TR S , and gap no. 3 contained the genomic termini, or the junction of TR S and U L when the genome is circularized. Based on the SalI restriction pattern, the estimated sizes for gaps 1, 2, and 3 were 1.0 kb, 0.6 kb, and 1.0 kb, respectively. Attempts to close these gaps by primer walking were partially successful. Gaps 1 and 3 were completely closed, and the sequence lengths were as predicted. Gap 2 could not be fully sequenced. Primer walking results revealed that this region contains repetitive units of very high G + C content (77%). Use of additional sequencing chemistry (i.e., dGTP BigDye Terminator) failed to sequence through this gap. The remaining ∼ 314 bp lacking sequence was tentatively filled with the same repetitive unit found at both ends of the gap. When sequences derived from the viral genome and BAC were compared to each other, they were completely identical, except for the insertion of the BAC vector at the left end of U L , an addition of a 2570-bp sequence in the BAC clone, and three aforementioned gaps whose sequence could only be determined from the BAC clone. A BLASTN search against the nonredundant nucleotide collection database nr/nt (Altschul et al., 1997) found that the additional sequence, located at bases no. 498-3067, did not resemble any known herpesvirus sequence. Overlapping PCRs using primers RM1025, RM1026, RM1484, RM1485, RM1486, RM1487, RM1493, RM1494, and RM1495 (Table 1) amplified bases no. 512-2373 from both the BAC clone and the DNA of uninfected Crandell-Reese feline kidney (CRFK) cells (data not shown). A BLAST search in the WGS Contigs database of the cat genome project (http://www.ncbi.nlm.nih.gov/projects/genome/ seq/BlastGen/BlastGen.cgi?pid=10703) revealed that the region between bases no. 2370 and 3052 was very similar to cat genomic DNA. Therefore, it is very likely that this sequence is a part of the cat genome, presumably acquired by the virus during the recombination process in CRFK cells.
The complete FHV-1 genomic sequence was compared to all FHV-1 DNA sequences in GenBank that contained at least one complete gene. The results are presented in Table 2 . The DNA sequences were highly similar across strains. The differences observed were mostly limited to single bases. It was noted that the copy number of repetitive sequences can vary between strains or even within the same strain.
The complete DNA sequences of the FHV-1 genome and the FHV-1 BAC clone were deposited in GenBank under accessions FJ478159 and GU250525, respectively.
Structure of the FHV-1 genome
The FHV-1 genome is 135,797 bp in length. The overall G + C content of FHV-1 genome is 45%. The genome consists of a 106,369-bp U L and an 8424-bp U S region, with the former being flanked by an inverted 33-bp sequence and the latter being flanked by IR S and TR S elements of 10,469 bp each.
ORF search, gene content, and gene arrangement
To identify all proteins encoded in the genome, we employed two methods. First, ORFs encoding proteins of ≥60 amino acids with a methionine start codon were evaluated for coding potential by searching for homologs in other alphaherpesviruses. Homology searches were conducted using BLASTX on the nonredundant protein sequence database nr (Altschul et al., 1997) . Other criteria used included compact gene arrangements on both strands with little gene overlap. To find novel genes in the FHV-1 genome ab initio and as a second approach to verify the annotation, the sequence was submitted to GeneMarkS (Besemer et al., 2001 ). GeneMarkS predicted 10 fewer genes, namely UL3, UL11, UL24, UL26.5, UL43, UL53, US2, US6, US8A, and US9. However, these genes are consistently present among varicelloviruses (Tables 3  and 4) , and they were easily identified using BLASTX, except for US2. Despite the low degree of sequence similarity, US2 was also predicted based on relative position similar to other varicelloviruses. Table 3 lists all FHV-1 ORFs predicted in the genomic sequence and summarizes the characteristics of the predicted gene products. The arrangement of these ORFs in the FHV-1 genome is shown in Fig. 3 . Seventy-eight ORFs were predicted in the FHV-1 genome, encoding 74 different proteins, as genes encoding ICP4, US1, and US10 proteins are found twice, once in the IR S and once in the TR S , and UL15 consists of two ORFs. Seventy-two ORFs are present as single copies with 64 located in the U L , 7 located entirely in the U S , and 1 that initiates in the U S and ends in the TR S . Three ORFs are located entirely in the repeat region, each present once in IR S and once in TR S . All ORF start locations were assumed to be the first possible ATG. The name of each protein was given based on its homology to HSV-1 and VZV genes. The predicted properties and functions assigned to each predicted gene were based on RefSeq annotations for other alphaherpesviruses in the database of the National Center for Biotechnology Information. In addition to the ORFs listed in Table 3 , 53 ORFs with a coding capacity of more The highest percent identity for each protein is indicated in bold.
than 60 amino acids were identified: 25 were found on the top strand and 28 were on the bottom strand. However, searches for cellular or viral homologs of these ORFs failed to find any significant match, and none of these ORFs was considered as strong candidates for new genes. Table 3 also lists the amino acid sequence similarity of each protein to their counterparts in the other sequenced varicelloviruses. All FHV-1 gene products showed some degree of homology to the gene products of the other varicelloviruses. Not surprisingly, genes involved in nucleotide metabolism, DNA replication, and packaging were among the most conserved. Glycoprotein genes were less conserved, although gB did show a high degree of similarity to gB of the other varicelloviruses. FHV-1 proteins were most similar to homologues of EHV-1 and EHV-4, averaging 49.4% and 49.2% animo acid identity, respectively. Phylogenetic relationships between FHV-1 and other varicelloviruses were examined using single glycoprotein and concatenated amino acid sequence alignments (McGeoch et al., 2000) . The results are presented in Fig. 4 and showed that FHV-1 is most closely related to EHV-1 and EHV-4.
The arrangement of FHV-1 genes is collinear with VZV, BHV-1, BHV-5, EHV-1, and EHV-4. The gene content is highly similar to those of varicelloviruses, especially EHV-1 and -4, with a few exceptions (Table 4) . FHV-1 lacks the homologs of V67 and US5, while both are present in EHV-1 and -4. V67 was found in EHV-1, EHV-4, BHV-1, BHV-5, and VZV, but it is absent in PRV. US5, encoding gJ, was found only in EHV-1 and -4. None of the genes identified was unique to FHV-1.
Polyadenylation signals and splice sites
The PolyADQ program (Tabaska and Zhang, 1999 ) was used to search for all potential polyadenylation signals in the FHV-1 genome. The search found 323 sites; each was given a score between 0 and 1. In the PRV study (Klupp et al., 2004) , experimental results were used to determine a cutoff score. Since there were very few, if any, data for the mapping of FHV-1 transcripts, every signal was located in the complete genomic sequence initially. Many signals did not associate with any upstream gene, while very often multiple signals were found for a given ORF or a set of coterminal transcripts. The polyadenylation signals for each gene were annotated based on the assumption that each transcript either ends near the termination codon or is a member of a 3′-coterminal family. The ones that are closest to the stop codon and have the highest scores were annotated.
UL15 is made up of two exons and is well conserved among herpesviruses. The region between and including the two exons of UL15 were submitted to the Neural Network Splice Site Prediction program conditioned for human splice site recognition (Reese et al., 1997) . The predicted donor site with the highest score (0.98) located 39 bp upstream from the end of the first ORF of UL15. The predicted acceptor site with the highest score (0.99) located between the ORF of UL17 and the second ORF of UL15. The spliced mRNA would encode a protein of 734 amino acids.
Origins of replication and tandem repeats
The origins of replication of herpesviruses are characterized by the presence of an AT-rich palindromic sequence. EHV-1, EHV-4, and PRV have at least three origins of DNA replication: one copy of OriL found in U L , between UL21 and UL22, and two copies of OriS found in IR S and TR S (Klupp et al., 2004; Telford et al., 1992 Telford et al., , 1998 . In contrast, VZV lacks an OriL (Davison and Scott, 1986 ). In the FHV-1 genome, the OriS palindrome was found in IR S and TR S . However, no sequence that resembles an OriL was found in the region between UL21 and UL22. Comparison of the DNA sequences in this region between the BAC clone and wildtype C-27 strain (data not shown) has ruled out the possibility that a similar palindrome might have been misassembled or deleted during cloning.
Using the Tandem Repeats Finder program (Benson, 1999) , eight different types of tandem repeat elements at 16 locations in the FHV-1 genome were identified (Table 5) . One tandem repeat element was found in U L , one in U S , and six in IR S /TR S . Four tandem repeat elements were located at genomic termini. No ORFs were found inside these repeats. One repeat is located inside ICP4, and Tandem Repeats Finder found an imperfect 78-mer repeat in UL44. The two repeat units have a 91% match with each other.
Reconstitution of virus particles from BAC clone and excision of the BAC vector
Virus particles were reconstituted from the BAC by transfecting CRFK cells with BAC DNA. The reconstituted virus, with the BAC vector in its genome, produced fluorescent plaques in CRFK monolayers (data not shown). To reduce possible effects the BAC vector might have on viral growth characteristics and virulence, CRFK cells were cotransfected with BAC DNA and pcDNA-Cre. pcDNA-Cre expresses Cre protein, which specifically recognizes the loxP sites flanking the BAC cassette and EGFP gene, excises them, and re-ligates the DNA leaving a single loxP site (Fig. 1) . After plaque purification, no fluorescent plaques were found. The excision of BAC vector was also verified by PCR and sequence analysis (data not shown). The BAC-excised FHV-1 BAC clone, FHV1ΔBAC, was used for subsequent in vitro and in vivo characterizations.
In vitro characterization of FHV1ΔBAC
To define the in vitro growth characteristics of the BAC-derived virus, plaque morphologies and multi-step growth curves for the C-27 strain and FHV1ΔBAC were compared. Plaques produced by the C-27 strain and FHV1ΔBAC virus are morphologically undistinguishable from each other. The average size of 100 plaques was determined for each virus strain. The mean plaque diameter of the FHV1ΔBAC virus was 101% of the C-27 parent strain and not significantly different (P = 0.740). Multistep growth curves were constructed for both the FHV1ΔBAC virus and the C-27 parent strain (Fig. 5) . At 48 and 72 hours p.i., the FHV1ΔBAC virus grew to titers 0.5-1.0 logs lower than those of the parent strain. Analysis of the growth curves by ANOVA indicated that the differences at 48 hours (P = 0.003) and 72 hours p.i. (P = 0.013) were statistically significant.
Preliminary in vivo characterization
To investigate possible attenuation resulting from BAC cloning, a preliminary challenge experiment was carried out using four specificpathogen-free (SPF) cats. Two cats were inoculated with the FHV1ΔBAC virus, one cat with the C-27 strain (positive control) and another cat was inoculated with cell culture medium (negative control). The results are summarized in Table 6 and Fig. 6 . The negative control cat did not show any clinical signs throughout the study. The cats inoculated with the C-27 strain and FHV1ΔBAC virus all developed similar clinical signs. The cumulative clinical scores of the FHV1ΔBAC-infected cats and the cat inoculated with the parent strain were comparable. Virus shedding was detected by virus isolation in the cats inoculated with the C-27 strain and the FHV1ΔBAC virus on days 3, 6, and 9 p.i. Virus neutralization tests demonstrated that the positive control cat and the FHV1ΔBAC virus-infected cats all showed seroconversion on day 14 p.i. The neutralizing antibody titers of the FHV1ΔBAC virus-infected cats and the cat inoculated with the parent strain were very similar.
Discussion
We report here the first BAC clone containing the entire C-27 strain FHV-1 genome that exhibits very high virulence in preliminary in vivo inoculation experiments. The restriction pattern of this BAC clone was nearly identical to that of the parent C-27 strain with all exceptions being related to the insertion of the BAC vector or circularization of the genome (Fig. 2) . The size of the genome, derived from both the sequence assembly and the restriction pattern analysis, is consistent with the literature (Rota et al., 1986 ).
An unexpected 2.7-kb cat DNA was inserted along with the BAC at the genomic termini. A possible explanation is the fact that herpesviruses can acquire parts of host genomes, through an unknown mechanism, during virus replication (Niikura et al., 2006) . The SalI K fragment, which contains three sets of tandem repeats in the TR S , has different sizes among bacterial clones (Fig. 2) . This is likely due to changes in the number of repeat units, as seen in different strains of FHV-1 ( Table 2) .
The BAC clone-derived FHV-1 virus was characterized in vitro by observing its plaque morphology and comparative growth curve analysis. Plaques produced by the BAC clone-derived virus were identical in size to those produced by the parent C-27 strain. The comparative growth curve analysis also showed that the BAC clone-derived virus can grow to N10 7 TCID 50 /ml, which was 0.5-1.0 logs lower than its parent strain (Fig. 5) . Although the BAC vector was excised from the genome through Cre-loxP recombination, parts of the recombination arms, as well as the cellular sequence, still remained (Fig. 1D) . The 
Table 6
Cumulative clinical score, virus shedding pattern, and virus neutralizing antibody titers of SPF cats inoculated with the C-27 parent strain, the FHV1ΔBAC strain, or mockinoculated with cell culture medium. presence of these sequences, totaling 3.5 kb, might have subtle influences on virus growth. In a limited in vivo study, the BAC clone-derived virus showed very similar pathogenicity in the infected cats. The delayed onset of clinical signs and the longer persistence (Fig. 6 ) could be related to the slightly slower replication of the BAC-derived virus, as shown in the in vitro characterization. However, since the number of cats used was very small, it could also be just a difference in susceptibility between individuals. Although the number was very small, the fact that both of the cats developed symptoms similar to the wild-type strain suggested that the BAC-derived virus is infectious, and its virulence appears to be similar to that of the parent strain. Moreover, in previous studies, it was shown that the symptoms induced by FHV-1 in experimentally infected cats are quite consistent (Kruger et al., 1996; Sussman et al., 1995) . The fact that this BAC-derived virus behaves very similarly to its parent strain both in vitro and in vivo makes it an excellent starting platform for defining the function of individual viral genes, especially those mediating the virulence of FHV-1.
We also present the first complete and annotated sequence of the FHV-1 genome, and a complete overview of the molecular composition of FHV-1. Before this study, sequencing efforts were focused on smaller fragments of the genome or individual genes from various strains. A full list of FHV-1 genes completely sequenced before this report is included in Table 2 . Envelope glycoprotein genes drew the most interest; 8 out of 11 had been completely sequenced.
The physical structure of the FHV-1 genome was first mapped in 1986 when Rota et al. (1986) reported a SalI restriction map of the C-27 strain. In 1991, Grail et al. (1991) mapped another strain of FHV-1, B927. The complete genomic sequence showed that the gene arrangement in the FHV-1 genome is collinear with that of many varicelloviruses, including BHV-1, BHV-5, EHV-1, EHV-4, and VZV. The shuffling of gene blocks found in the PRV genome did not appear in the FHV-1 genome of this strain.
In conclusion, the FHV-1 BAC clone we report contains the entire FHV-1 genome, the BAC clone-derived virus grows to slightly lower titers in vitro compared to the C-27 parent strain, and its plaque morphology is not significantly altered. Preliminary indications are that its in vivo virulence is also similar to that of the C-27 parent strain. Recent advances in recombineering (recombination-mediated genetic engineering) techniques have made it easier to introduce site-specific mutations into a BAC clone (Tischer et al., 2006) . In addition, random libraries of herpesvirus BAC mutants can be generated by the use of transposon-mediated insertion mutagenesis (Brune et al., 1999) . These characteristics, along with the availability of the complete genome sequence, will make the BAC clone an excellent starting platform for future mutagenesis-based functional studies of viral genes and ultimately for future vaccine development.
Materials and methods
Cells and viruses
CRFK cells (ATCC, Manassas, VA) were cultured in Eagle's minimum essential medium (EMEM) containing 10% fetal bovine serum (FBS) and 10 μg/ml ciprofloxacin. The FHV-1 prototype strain C-27 (ATCC, Manassas, VA) was propagated in the CRFK cells and used as wild-type virus throughout this study. The purified FHV-1 virions were prepared by pelleting the supernatant through a 20% potassium tartrate cushion at 24,000 × g for 2 hours at 4°C.
Plasmids and vectors
The 0.6-kb upstream homologous region, which includes the 3′-end of US3 gene, the intergenic region of US3 and US4, and the 5′-end of US4 (gG) gene, was amplified from purified FHV-1 genomic DNA by PCR using the Extended High Fidelity PCR System (Roche Applied Science, Indianapolis, IN) with the following primers: RM0874, which contains a MluI site at the 5′-end; and RM0875, which contains a SwaI site, a BsiWI site, and a loxP site at the 5′-end (Table 1 ). The PCR product was cloned into a pCRII vector (Invitrogen, Carlsbad, CA), resulting in pCRII-UgG.
The 1.0-kb downstream homologous region, which includes the intergenic region of US4 (gG) and US6 (gD), and the 5′-end of US6 (gD) gene, was amplified from purified FHV-1 genomic DNA by PCR using the Extended High Fidelity PCR System with the following primers: RM0876, which contains a HindIII site, a SalI site, and a loxP site at the 5′-end; and RM0877, which contains a MluI site at the 5′-end (Table 1 ). The PCR product was also cloned into a pCRII vector, resulting in pCRII-DgG.
pCRII-EGFPm2 was constructed as follows. The vector pEGFP-N1 (Clontech Laboratories, Mountain View, CA) was digested by XhoI and SalI and re-ligated, eliminating XhoI, SacI, HindIII, and SalI sites. The 1.6-kb region containing the modified EGFP expression cassette, which includes the CMV immediate early promoter, the EGFP ORF, and SV40 early mRNA polyadenylation signal, was amplified from the modified pEGFP-N1 by PCR using Extended High Fidelity PCR System with the following primers: RM0872, which contains a BsiWI site at the 5′-end, and RM0873, which contains a SacI and SalI site at the 5′-end (Table 1 ). The PCR product was cloned into a pCRII vector, resulting in pCRII-EGFPm2.
pGEM3Zf-DUgG2, which contains two homologous regions and two loxP sites, was constructed by ligation of the following fragments: the MluI-SwaI fragment of pCRII-UgG, the HindIII-MluI fragment of pCRII-DgG, and the pGEM-3Zf vector (Promega, Madison, WI), digested with HindIII and SmaI.
pGEM3Zf-DUgGEGFP2, which contains two homologous regions, two loxP sites, and an EGFP expression cassette, was constructed as follows: pCRII-EGFPm2 was digested with BsiWI and SacI, and the fragment containing EGFP expression cassette was ligated with pGEM3Zf-DUgG2, also digested with BsiWI and SacI.
To target the BAC cassette insertion site to US4, the BAC vector pBAC04, which contains the BAC cassette, two (upstream and downstream) homologous recombination arms between two loxP sites and an EGFP expression cassette, was constructed as follows. The BAC vector pBeloBAC11 (Invitrogen, Carlsbad, CA) was digested with SalI and dephosphorylated; the 6.4-kb fragment was purified and ligated with the SalI fragment of pGEM3Zf-DUgGEGFP2.
To construct pcDNA-Cre, a plasmid that expresses Cre recombinase, the entire ORF of Cre was excised by KpnI and SmaI digestions from pGIKS-Cre (ATCC, Manassas, VA) and ligated with pcDNA3.1 vector (Invitrogen, Carlsbad, CA), digested with KpnI and EcoRV.
All the plasmid constructs were verified by both restriction digestion and sequencing. pBAC04 was transformed into the E. coli strain DH10B (Invitrogen, Carlsbad, CA). All the other constructs were transformed into the E. coli strains TOP10 or DH5α (both from Invitrogen). The transformants were plated on selective agar that contained 75 μg/ ml ampicillin or 34 μg/ml chloramphenicol.
DNA extraction
Pure viral genomic DNA was prepared as follows: Purified virions were incubated in lysis buffer (0.1 M Tris-Cl, pH 8.0, 1 mM EDTA, 1% SDS) with 50 μg/ml proteinase K at 37°C. DNA was subsequently extracted with phenol-chloroform-isoamylalcohol (25:24:1) and precipitated with 100% ethanol. Care was used to avoid shearing the DNA. High-copy number plasmids were extracted using the Plasmid Mini Kit (Qiagen, Valencia, CA). Small-scale BAC DNA purifications were carried out using the alkaline lysis method (Sambrook and Russell, 2001 ). Large-scale and high-purity BAC DNA purifications were carried out using the Large Construct Kit (Qiagen, Valencia, CA) following the manufacturer's instructions.
BAC cloning
The strategy used for cloning FHV-1 genome as a BAC exploits spontaneous homologous recombinations in the transfected CRFK cells was similar to those used in previous reports (Costes et al., 2006; Niikura et al., 2006) . To reduce possible sequence alterations during in vitro passage in cell culture, low-passage C-27 strain virus (P4) was used for BAC cloning. Purified FHV-1 genomic DNA and pBAC04 were cotransfected into CRFK cells using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The supernatant of cotransfected cells was collected for plaque assay, and plaques were examined for EGFP expression. One virus clone that consistently produced fluorescent plaques was obtained. After two times of plaque purification, CRFK cells were inoculated with this virus clone, and the circular form replication intermediate of the virus genome was extracted from the cells using the method of Hirt (1967) and transformed into E. coli DH10B cells. Colonies growing on the chloramphenicol plate were examined for the presence of FHV-1 genome and BAC vector by restriction pattern analysis and PCR.
Reconstitution of infectious virus from BAC
The CRFK cells were cotransfected with 1 μg of the BAC DNA and 1 μg of pcDNA-Cre using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions.
Sequencing, sequence assembly, and gap closure
The majority of the sequence was determined by shotgun sequencing using the high-throughput pyrosequencing instrument Genome Sequencer 20 (Roche Applied Science, Indianapolis, IN) at the Genomics Core of Michigan State University's Research Technology Support Facility (RTSF). The reads were assembled using the Newbler assembly program (Roche Applied Science, Indianapolis, IN) at the Bioinformatics Core of RTSF. Gaps were closed by primer walking. Gap closure was carried out using BigDye Terminator 3.0 and dGTP BigDye Terminator chemistries and Gene Analyzer 3100 (Applied Biosystems, Foster City, CA).
ORF finding and sequence analysis
To identify the genes encoded in the FHV-1 genome, all potential ORFs with a minimum length of 60 codons and a methionine as start codon were analyzed for homology to known proteins using BLASTX against nonredundant protein database (Altschul et al., 1997) . To find novel genes in the FHV-1 genome ab initio, and as a second approach to verify the annotation, the sequence was submitted to GeneMarkS (Besemer et al., 2001) . To search for polyadenylation signals, the FHV-1 genome sequence was submitted to PolyADQ, a eukaryotic polyadenylation signal search engine (Tabaska and Zhang, 1999) . The Neural Network Splice Site Prediction program conditioned for human splice site recognition (Reese et al., 1997) was used to identify possible splice donor and acceptor sites of UL15. The Tandem Repeats Finder program (Benson, 1999) was used to search for tandem repeats. Phylogenetic analyses were carried out using the MEGA4 software (Tamura et al., 2007) .
Plaque morphology
One hundred fifty TCID 50 units of the virus was inoculated on CRFK monolayers. After a 1-hour adsorption, the diluted viruses were removed, and fresh growth medium was added. The cells were then incubated at 37°C in an atmosphere of 5% CO 2 . After 40 hours of incubation, 100 plaques produced by each virus were photographed and the diameters were determined using the QCapture software (QImaging, Surrey, British Columbia, Canada). The measurements were analyzed by ANOVA.
Multi-step growth curve
The wild-type virus and the BAC clone were inoculated on CRFK monolayers in triplicate at an m.o.i. of 0.01. After a 1-hour adsorption, the diluted viruses were removed, and the cells were overlaid with fresh medium. The first supernatant samples were collected at this time as 0-hour p.i. The monolayers were then incubated at 37°C in an atmosphere of 5% CO 2 . Supernatants were collected at 0, 6, 24, 48, and 72 hours p.i. and stored at − 80°C until titration. The mean titers of each time point were analyzed by ANOVA.
Cats
Four 12-week-old female SPF cats were used (Liberty Research, Waverly, NY). Cats were housed in individual cages in rooms with controlled temperature, humidity, and lighting. They were fed a combination of dry and moist diets. Each group of cats was housed in a separate Biocontainment Level-2 room. All cats were acclimated for 13 days before virus exposure. Two cats were inoculated oronasally with 2 × 10 5 TCID 50 of the FHV1ΔBAC. The other two cats were either inoculated oronasally with 2 × 10 5 TCID 50 of the C-27 strain wild-type virus (positive control) or cell culture medium (negative control). The titers were rechecked before inoculation. Clinical signs induced by inoculation of the viruses were scored as described in the USDA Supplemental Assay Method 311 (U.S. Department of Agriculture, Animal and Plant Health Inspection Service, National Animal Veterinary Services Laboratory, 1985; Table 1 ). Oral swabs were collected from each cat at days 0, 3, 6, 9, 14, and 21 p.i. for virus isolation. Serum samples were collected from each cat at days 0, 14, and 21 p.i. for virus neutralization testing. The cat study was reviewed and approved by the Institutional Animal Care and Use Committee at Michigan State University.
